跳至主要内容
临床试验/JPRN-UMIN000047503
JPRN-UMIN000047503已完成未知

Investigation of the effect of dual antithrombotic therapy with prasugrel in patients with atrial fibrillation after drug-eluting stent implantation for coronary artery disease - CHIBA AF-PCI registry

Chiba University0 个研究点目标入组 949 人开始时间: 2022年4月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
949

研究概览

简要总结

In AF patients undergoing PCI, DAT was associated with lower incidence of MACE and major bleed- ing events compared with TAT. In comparison of P2Y12i, there might be no significant difference in the incidence of MACE and bleeding events between prasugrel-based DAT and clopidogrel-based DAT.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. PCI with two stent technique for bifurcation lesion 2. history of stent thrombosis 3. mechanical valve or bioprosthetic valve 4. cardiogenic shock 5. history of stroke, major surgery, gastrointestinal bleeding within 1 month 6. hemorrhagic disease or diathesis 7. severe renal dysfunction 8. severe lever dysfunction 9. allergy for warfarin, dabigatran, rivaroxaban, apixaban, edoxaban, or prasugrel 10. pregnancy 11. scheduled for surgery

研究者

相似试验